Johnson & Johnson JNJ Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $24.06B-2.0% | $24.56B+2.4% | $23.99B+1.1% | $23.74B+8.5% | $21.89B-2.8% | ||
| $8.11B+1.7% | $7.97B+9.1% | $7.3B-4.3% | $7.63B+3.7% | $7.36B+3.2% | ||
| $15.96B-3.9% | $16.6B-0.6% | $16.69B+3.6% | $16.12B+10.9% | $14.54B-5.6% | ||
| 66.3%-1.3pp | 67.6%-2.0pp | 69.6%+1.7pp | 67.9%+1.5pp | 66.4%-2.0pp | ||
| $6.03B-10.6% | $6.75B+14.0% | $5.92B+0.6% | $5.89B+15.2% | $5.11B-20.8% | ||
| $32M-61.9% | $84M+33.3% | $63M-1.6% | $64M+276% | $17M-59.5% | ||
| $6.33B+16.6% | $5.43B-22.8% | $7.03B+5.8% | $6.65B+7.5% | $6.18B+72.6% | ||
| 26.3%+4.2pp | 22.1%-7.2pp | 29.3%+1.3pp | 28%-0.2pp | 28.2%+12.3pp | ||
| $272M+27.1% | $214M-12.7% | $245M-20.5% | $308M+51.0% | $204M+48.9% | ||
| $229M-3.4% | $237M+4.4% | $227M-12.7% | $260M-21.7% | $332M+18.1% | ||
| $5.99B+20.6% | $4.97B-33.7% | $7.49B+15.4% | $6.49B-52.4% | $13.63B+251% | ||
| $755M— | $0-100% | $2.34B+145% | $954M-63.8% | $2.63B+477% | ||
| $5.24B+2.3% | $5.12B-0.7% | $5.15B-7.0% | $5.54B-49.7% | $11B+221% | ||
| 21.8%+0.9pp | 20.8%-0.6pp | 21.5%-1.8pp | 23.3%-26.9pp | 50.2%+35.0pp | ||
| $2.14+2.4% | $2.09-1.4% | $2.12-7.4% | $2.29-49.6% | $4.54+222% | ||
| $2.17+2.4% | $2.12-0.9% | $2.14-7.0% | $2.30-49.7% | $4.57+222% | ||
| 2.4B+0.7% | 2.4B0.0% | 2.4B+0.4% | 2.4B-0.2% | 2.4B-0.2% | ||
| 2.4B+0.1% | 2.4B0.0% | 2.4B+0.1% | 2.4B0.0% | 2.4B0.0% | ||
| 33.7%— | —— | 30.4%-1.7% | 32.1%-1.5% | 33.6%— | ||
| 66.3%— | —— | 69.6%+1.7% | 67.9%+1.5% | 66.4%— | ||
| 24.9%— | —— | 31.2%+3.9% | 27.3%-35.0% | 62.3%— | ||
| 3.1%— | —— | 9.7%+5.7% | 4%-8.1% | 12.1%— | ||
| 1.2%— | —— | 1%-0.3% | 1.3%+0.4% | 0.9%— | ||
| -1%— | —— | -0.9%+0.2% | -1.1%+0.4% | -1.5%— | ||
| 1.2%— | —— | -2%-2.5% | 0.5%+33.9% | -33.4%— | ||
| -$294M— | $0-100% | $478M+547% | -$107M-101% | $7.32B— | ||
| $3.53B-17.1% | $4.25B+15.8% | $3.67B+4.4% | $3.52B+9.0% | $3.23B-39.1% | ||
| 14.7%— | —— | 15.3%+0.5% | 14.8%+0.1% | 14.7%— | ||
| $36M-55.6% | $81M— | $0— | $0— | $0-100% | ||
| 0.1%— | —— | —— | 0%— | 0%— | ||
| 0.1%— | —— | 0.3%0.0% | 0.3%+0.2% | 0.1%— | ||
| $24.06B-2.0% | $24.56B+2.4% | $23.99B+1.1% | $23.74B+8.5% | $21.89B-2.8% | ||
| 100%— | —— | 100%0.0% | 100%0.0% | 100%— | ||
| 25.1%— | —— | 24.7%-0.1% | 24.8%+1.5% | 23.3%— | ||
| $8.33B+12.0% | $7.44B-15.6% | $8.81B+2.6% | $8.59B+8.0% | $7.95B+45.2% | ||
| 34.6%+4.3pp | 30.3%-6.4pp | 36.7%+0.5pp | 36.2%-0.2pp | 36.3%+12.0pp | ||
| $6.33B+16.6% | $5.43B-22.8% | $7.03B+5.8% | $6.65B+7.5% | $6.18B+72.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Johnson & Johnson's revenue?
- Johnson & Johnson (JNJ) generated $96.4B in revenue over the trailing twelve months, up 7.9% year over year.
- Is Johnson & Johnson profitable?
- Johnson & Johnson reported $21.0B in net income over the trailing twelve months, a 21.8% net margin.
- What are Johnson & Johnson's profit margins?
- Gross margin is 67.8% and operating margin is 26.4%, with a 21.8% net margin.
- What is Johnson & Johnson's earnings per share?
- Johnson & Johnson's diluted EPS over the trailing twelve months is $8.64.
- Where does Johnson & Johnson's income statement data come from?
- Every line is extracted from Johnson & Johnson's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
